CD47-SIRPα Checkpoint Disruption in Metastases Requires Tumor-Targeting Antibody for Molecular and Engineered Macrophage Therapies

by Andrechak, J.C, Discher, D.E, Dooling, L.J, Hayes, B.H, Irianto, J., Jin, X., Lee, J.Y, Tobin, M.P, Zhang, W.
Published 2022